Resources at the ready

Download these useful tools to learn more about ELITEK

Read the Core Visual Aid for an in-depth overview of ELITEK clinical data and dosing and administration details

Use this Risk Assessment Tool to help identify patients who may be at risk for TLS

Use this efficacy and safety flashcard to see the head-to-head pivotal trial data between ELITEK and allopurinol

Reference this MOA flashcard for an overview of how ELITEK works

Reference the pediatric brochure to see the ELITEK trial designs and results for a pediatric patient population

Download these resources for information to assist you in evaluating ELITEK

Meet Victor, a high-risk DLBCL patient with normal uric acid levels

Meet Sarah, a CLL patient with hyperuricemia

CLL=chronic lymphocytic leukemia; DLBCL=diffuse large B-cell lymphoma.